Spots Global Cancer Trial Database for recurrent malignant testicular germ cell tumor
Every month we try and update this database with for recurrent malignant testicular germ cell tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer | NCT00004077 | Testicular Germ... | cisplatin ifosfamide paclitaxel | 16 Years - 64 Years | National Cancer Institute (NCI) | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors | NCT00002508 | Extragonadal Ge... Ovarian Cancer Testicular Germ... | carboplatin etoposide autologous bone... peripheral bloo... | 15 Years - 60 Years | Temple University | |
| Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma | NCT00082823 | Cancer | ziv-aflibercept | 18 Years - 120 Years | Regeneron Pharmaceuticals | |
| Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin | NCT00002559 | Ovarian Cancer Testicular Germ... | filgrastim cisplatin ifosfamide paclitaxel | 15 Years - | Memorial Sloan Kettering Cancer Center | |
| Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment | NCT00453310 | Extragonadal Ge... Ovarian Cancer Teratoma Testicular Germ... | sunitinib malat... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors | NCT00003173 | Brain and Centr... Childhood Germ ... Extragonadal Ge... Ovarian Cancer Retinoblastoma Testicular Germ... Unspecified Adu... Unspecified Chi... | filgrastim thiotepa autologous bone... peripheral bloo... | - | Memorial Sloan Kettering Cancer Center | |
| Arsenic Trioxide in Treating Men With Germ Cell Cancer | NCT00036842 | Extragonadal Ge... Testicular Germ... | arsenic trioxid... | 16 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors | NCT00301782 | Extragonadal Ge... Teratoma Testicular Germ... | bleomycin sulfa... carboplatin cisplatin etoposide phosp... vincristine sul... | 16 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors | NCT00002558 | Extragonadal Ge... Ovarian Cancer Testicular Germ... | filgrastim carboplatin etoposide ifosfamide paclitaxel peripheral bloo... | 15 Years - | Memorial Sloan Kettering Cancer Center | |
| Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors | NCT00551122 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ... | filgrastim lenograstim pegfilgrastim cisplatin gemcitabine hyd... ifosfamide paclitaxel | 16 Years - 60 Years | University of Southampton | |
| Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors | NCT00957905 | Recurrent Extra... Recurrent Malig... Recurrent Malig... Recurrent Malig... Recurrent Ovari... Stage III Testi... Stage IV Extrag... Stage IV Extrag... Stage IV Ovaria... | Alvocidib Hydro... Fluorouracil Leucovorin Calc... Oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer | NCT00002903 | Extragonadal Ge... Ovarian Cancer Testicular Germ... | docetaxel | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer | NCT00027534 | Breast Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Head and Neck C... Liver Cancer Ovarian Cancer Pancreatic Canc... Testicular Germ... | TRICOM-CEA(6D) | 18 Years - | Duke University | |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer | NCT00003704 | Cancer | capecitabine radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors | NCT00002566 | Extragonadal Ge... Testicular Germ... | carboplatin cisplatin cyclophosphamid... etoposide ifosfamide vinblastine sul... autologous bone... conventional su... peripheral bloo... | 16 Years - 120 Years | UNICANCER | |
| Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors | NCT00551122 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ... | filgrastim lenograstim pegfilgrastim cisplatin gemcitabine hyd... ifosfamide paclitaxel | 16 Years - 60 Years | University of Southampton | |
| Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer | NCT00042952 | Ovarian Dysgerm... Recurrent Malig... Recurrent Ovari... Stage II Malign... Stage II Ovaria... Stage III Malig... Stage III Ovari... Testicular Semi... | imatinib mesyla... therapeutic con... laboratory biom... | 15 Years - | National Cancer Institute (NCI) | |
| Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer | NCT00002903 | Extragonadal Ge... Ovarian Cancer Testicular Germ... | docetaxel | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors | NCT00467051 | Childhood Extra... Childhood Extra... Childhood Malig... Childhood Malig... Ovarian Chorioc... Ovarian Embryon... Ovarian Yolk Sa... Recurrent Child... Recurrent Malig... Recurrent Ovari... Testicular Chor... Testicular Embr... Testicular Mixe... Testicular Mixe... Testicular Mixe... Testicular Yolk... | Carboplatin Filgrastim Ifosfamide Laboratory Biom... Paclitaxel | - 21 Years | Children's Oncology Group | |
| Arsenic Trioxide in Treating Men With Germ Cell Cancer | NCT00036842 | Extragonadal Ge... Testicular Germ... | arsenic trioxid... | 16 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors | NCT00019331 | Colorectal Canc... Endometrial Can... Head and Neck C... Liver Cancer Lung Cancer Melanoma (Skin) Pancreatic Canc... Testicular Germ... Unspecified Adu... | aldesleukin ras peptide can... sargramostim DetoxPC | 18 Years - | National Cancer Institute (NCI) | |
| Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors | NCT00070096 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ... | ixabepilone | 16 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors | NCT00002558 | Extragonadal Ge... Ovarian Cancer Testicular Germ... | filgrastim carboplatin etoposide ifosfamide paclitaxel peripheral bloo... | 15 Years - | Memorial Sloan Kettering Cancer Center | |
| Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma | NCT00083213 | Cancer | ziv-aflibercept | 18 Years - 120 Years | Regeneron Pharmaceuticals | |
| Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors | NCT00453232 | Extragonadal Ge... Teratoma Testicular Germ... | bleomycin sulfa... pegfilgrastim cisplatin etoposide | 18 Years - 40 Years | National Cancer Institute (NCI) | |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer | NCT00003704 | Cancer | capecitabine radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer | NCT01132547 | Cancer | cyproheptadine ... placebo | 2 Years - 21 Years | University of South Florida | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors | NCT00003852 | Childhood Germ ... Extragonadal Ge... Ovarian Cancer Testicular Germ... | filgrastim carboplatin cyclophosphamid... epirubicin hydr... etoposide ifosfamide paclitaxel thiotepa bone marrow abl... peripheral bloo... | 15 Years - 120 Years | UNICANCER | |
| Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin | NCT00423852 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Teratoma Testicular Germ... | filgrastim carboplatin ifosfamide paclitaxel autologous hema... peripheral bloo... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression | NCT01433224 | Childhood Germ ... Extragonadal Ge... Ovarian Cancer Testicular Germ... | DNA methylation... RNA analysis mutation analys... nucleic acid se... polymerase chai... polymorphism an... laboratory biom... medical chart r... | - | Children's Oncology Group | |
| Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer | NCT00060372 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Atypical Chroni... Childhood Myelo... Chronic Myeloge... Disseminated Ne... Malignant Neopl... Ovarian Chorioc... Ovarian Embryon... Ovarian Immatur... Ovarian Mature ... Ovarian Mixed G... Ovarian Monoder... Ovarian Polyemb... Ovarian Yolk Sa... Previously Trea... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Malig... Recurrent Mantl... Recurrent Neuro... Recurrent Ovari... Recurrent Ovari... Refractory Chro... Refractory Mult... Relapsing Chron... Stage I Multipl... Stage II Multip... Stage II Ovaria... Stage III Malig... Stage III Multi... Stage III Ovari... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Ovaria... Testicular Chor... Testicular Chor... Testicular Chor... Testicular Chor... Testicular Chor... Testicular Embr... Testicular Embr... Testicular Embr... Testicular Embr... Testicular Embr... Testicular Embr... Testicular Tera... Testicular Yolk... Testicular Yolk... Testicular Yolk... | ipilimumab therapeutic all... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer | NCT00002931 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Teratoma Testicular Germ... | filgrastim carboplatin etoposide ifosfamide paclitaxel autologous bone... bone marrow abl... | 16 Years - 120 Years | City of Hope Medical Center | |
| Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions | NCT00066404 | Cancer | recombinant ade... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors | NCT00072215 | Extragonadal Ge... Testicular Germ... | cisplatin ifosfamide paclitaxel vinblastine | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions | NCT00066404 | Cancer | recombinant ade... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin | NCT00006043 | Ovarian Cancer Testicular Germ... | temozolomide | 16 Years - | Memorial Sloan Kettering Cancer Center | |
| Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors | NCT00957905 | Recurrent Extra... Recurrent Malig... Recurrent Malig... Recurrent Malig... Recurrent Ovari... Stage III Testi... Stage IV Extrag... Stage IV Extrag... Stage IV Ovaria... | Alvocidib Hydro... Fluorouracil Leucovorin Calc... Oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer | NCT00002943 | Extragonadal Ge... Ovarian Cancer Testicular Germ... Unspecified Adu... | carboplatin cyclophosphamid... etoposide autologous bone... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery | NCT00006126 | Breast Cancer Kidney Cancer Lung Cancer Melanoma (Skin) Testicular Germ... | busulfan cyclophosphamid... etoposide fludarabine pho... peripheral bloo... radiation thera... | - 59 Years | Northwestern University | |
| Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors | NCT00070096 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ... | ixabepilone | 16 Years - | National Cancer Institute (NCI) | |
| Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors | NCT00551122 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ... | filgrastim lenograstim pegfilgrastim cisplatin gemcitabine hyd... ifosfamide paclitaxel | 16 Years - 60 Years | University of Southampton | |
| Biological Therapy in Treating Patients With Metastatic Cancer | NCT00004604 | Breast Cancer Colorectal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Head and Neck C... Liver Cancer Lung Cancer Metastatic Canc... Ovarian Cancer Pancreatic Canc... Testicular Germ... | CEA RNA-pulsed ... | 18 Years - | Duke University | |
| Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma | NCT00082823 | Cancer | ziv-aflibercept | 18 Years - 120 Years | Regeneron Pharmaceuticals | |
| High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy | NCT01172912 | Brain and Centr... Extragonadal Ge... Testicular Germ... | filgrastim pegfilgrastim carboplatin cisplatin dexamethasone etoposide ifosfamide high-dose chemo... laboratory biom... autologous hema... peripheral bloo... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer | NCT00003704 | Cancer | capecitabine radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors | NCT00499291 | Cancer | paclitaxel albu... gene expression... laboratory biom... pharmacological... polymerase chai... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin | NCT00006043 | Ovarian Cancer Testicular Germ... | temozolomide | 16 Years - | Memorial Sloan Kettering Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
